Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
2022 · Journal of Hematology & Oncology · 187 citations
https://doi.org/10.1186/s13045-022-01362-9
X
Xiaoli Sun
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
1.0K
Citations
15
h-index
17
i10-index
Xiaoli Sun is an academic researcher from Nanjing Tech University. The author has contributed to research in topics: Antibiotic Resistance in Bacteria & Pharmaceutical and Antibiotic Environmental Impacts & Advanced biosensing and bioanalysis techniques. The author has an h-index of 15, co-authored 43 publications.
Papers by this author
worksMetformin reverse minocycline to inhibit minocycline-resistant Acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro
2022 · BMC Microbiology · 12 citations
https://doi.org/10.1186/s12866-022-02629-4
Mitochondrial genomes of Meghimatium pictum and Succinea arundinetorum provide insight into the gene order rearrangement within Stylommatophora (Gastropoda, Panpulmonata)
2025 · BMC Zoology · 1 citations
https://doi.org/10.1186/s40850-025-00239-x
No Interaction, No Watching: Watching Characteristics of the Social Short Video Era
2025 · Critical Arts · 0 citations
https://doi.org/10.1080/02560046.2025.2483951
Effect of temperature on the interaction rules between grain size and reaction rate of Al-Ga-based alloys for hydrogen generation
2025 · Journal of Alloys and Compounds · 0 citations
https://doi.org/10.1016/j.jallcom.2025.180182
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat